Differences in Tacrolimus Troughs and Doses Between Caucasians and African Americans with Two CYP3A5 Loss-of-Function Alleles: Looking Beyond CYP3A5 Expression.

被引：0
|
作者：
Oetting, W. [1 ]
Schladt, D. [2 ,3 ]
Guan, W. [1 ]
Remmel, R. [1 ]
Dorr, C. [2 ,3 ]
Sanghavi, K. [1 ]
Matas, A. [1 ]
Mannon, R. [4 ]
Israni, A. [2 ,3 ]
Jacobson, P. [1 ]
机构：
[1] Univ Minnesota, Minneapolis, MN USA
[2] Hennepin Cty Med Ctr, Minneapolis, MN USA
[3] Minneapolis Med Res Fdn Inc, Minneapolis, MN USA
[4] Univ Alabama Birmingham, Birmingham, AL USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C251
引用
收藏
页码：681 / 682
页数：2
相关论文
共 50 条
  • [1] Tacrolimus troughs in Caucasians with two CYP3A5 loss-of-function alleles: Evidence for additional genetic influences using a genome wide association study
    Oetting, W. S.
    Wu, B.
    Schladt, D. P.
    Guan, W.
    Remmel, R. P.
    Mannon, R. B.
    Matas, A. J.
    Israni, A. K.
    Jacobson, P. A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 695 - 696
  • [2] Importance of genotyping CYP3A5*6 and CYP3A5*7 alleles in determining the tacrolimus daily dose
    Fonrose, X.
    Roustit, M.
    Broly, F.
    Rey, I.
    Malvezzi, P.
    Janbon, B.
    Boyle, F.
    Hardy, G.
    Lunardi, J.
    Bessard, G.
    Stanke-Labesque, F.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 56 - 56
  • [3] Differential impact of the CYP3A5*1 and CYP3A5*3 alleles on pre-dose concentrations of two tacrolimus formulations
    Wehland, Markus
    Bauer, Steffen
    Brakemeier, Susanne
    Burgwinkel, Philip
    Glander, Petra
    Kreutz, Reinhold
    Lorkowski, Christine
    Slowinski, Torsten
    Neumayer, Hans H.
    Budde, Klemens
    PHARMACOGENETICS AND GENOMICS, 2011, 21 (04): : 179 - 184
  • [4] Differential Impact of the CYP3A5*1/*3 Alleles on the Pharmacokinetics of Two Tacrolimus Formulations
    Budde, Klemens
    Wehland, Markus
    Bauer, Steffen
    Brakemeier, Susanne
    Burgwinkel, Philip
    Glander, Petra
    Kreutz, Reinhold
    Lorkowski, Christine
    Slowinski, Torsten
    Neumayer, Hans H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 295 - 295
  • [5] Effect of CYP3A5 genotype on the relationship between hepatic CYP3A activity and CYP3A4 and CYP3A5 mRNA expression
    Kolwankar, D
    Ho, H
    Ethell, B
    Vuppalanchi, R
    Marri, SR
    Wrighton, SA
    Jones, DR
    Hall, SD
    DRUG METABOLISM REVIEWS, 2004, 36 : 118 - 118
  • [6] The influence of CYP3A5 genotype on dexamethasone induction of CYP3A activity in African Americans
    Roberts, Patrick J.
    Rollins, Kristan D.
    Kashuba, Angela D. M.
    Paine, Mary F.
    Nelsen, Andrew C.
    Williams, Eric E.
    Moran, Cassandra
    Lamba, Jatinder K.
    Schuetz, Erin G.
    Hawke, Roy L.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (08) : 1465 - 1469
  • [7] Impact of the CYP3A5*1/*3 alleles on the pharmacokinetics of two tacrolimus formulations after renal transplantation
    Bartling, P.
    Wehland, M.
    Brakemeier, S.
    Bauer, S.
    Glander, P.
    Slowinski, T.
    Neumayer, H. H.
    Budde, K.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 508 - 508
  • [8] Influence of CYP3A5 genotype on the extent of CYP3A inhibition in healthy African-Americans
    Isoherranen, Nina
    Paine, Mary F.
    Givens, Raymond C.
    Ludington, Shana S.
    Hawke, Roy L.
    Pusek, Susan N.
    Dees, E. Claire
    Blough, David
    Iwanaga, Kazunori
    Watkins, Paul B.
    Thummel, Kenneth E.
    DRUG METABOLISM REVIEWS, 2006, 38 : 89 - 89
  • [9] ASSOCIATION BETWEEN TACROLIMUS AND CYP3A5 GENOTYPE IN PEDIATRIC KIDNEY TRANSPLANT
    Alghamdi, A.
    Lazear, D.
    Varnell, C.
    Seay, S.
    Hooper, D.
    Darland, L.
    Mizuno, T.
    Ramsey, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S10 - S10
  • [10] Differences in verapamil response between CYP3A5 genotypes.
    Langaee, TY
    Yarandi, HN
    Katz, DA
    Dehoff, RM
    Kehoe, JM
    Klocman, AS
    Pepine, CJ
    Johnson, JA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P12 - P12
12345